The Inconsistent and Inadequate Reporting Of Immune‐Related Adverse Events in PD‐1/PD‐L1 Inhibitors: A Systematic Review of Randomized Controlled Clinical Trials

BACKGROUND: Immune‐related adverse events (irAEs) are of great interest and importance in clinical practice, and many deficiencies and controversies have been noted in the reporting of irAEs. Herein, we aimed to evaluate the current status of irAE reporting in randomized controlled clinical trials (...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Tong, Zhang, Zhening, Qi, Changsong, Lu, Ming, Zhang, Xiaotian, Li, Jian, Shen, Lin, Peng, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Immuno‐Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649005/
https://www.ncbi.nlm.nih.gov/pubmed/34396642
http://dx.doi.org/10.1002/onco.13940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649005/
https://www.ncbi.nlm.nih.gov/pubmed/34396642
http://dx.doi.org/10.1002/onco.13940

Ejemplares similares